Ayahuasca, a psychedelic brew traditionally used by Amazonian peoples, has spread to urban areas worldwide, raising concerns about potential health risks. A review of 15 studies from the PubMed database examined the emotional, cognitive, and physical health effects of ayahuasca use after acute effects subsided. The accumulated data suggest that ayahuasca use is safe and may even be beneficial under certain conditions. However, methodological bias in the reviewed studies may have contributed to the preponderance of beneficial effects and the few adverse effects reported. The data do not yet allow definitive conclusions about ayahuasca's effects on mental and physical health, but some studies point toward beneficial outcomes.
A Brazilian Portuguese version of the Hallucinogen Rating Scale (HRS) has been produced through translation, back-translation, and committee review, following guidelines for semantic and conceptual equivalence. The HRS is a standard questionnaire used in the U.S. and Europe to evaluate subjective effects of hallucinogens, including ayahuasca. The final version is intended to provide a sensitive instrument for quantifying hallucinogen-induced states in Brazil, where scientific interest in such substances is growing.
Ayahuasca shows promise in treating substance abuse, with a study involving 100 participants revealing that 60% reported significant reductions in substance use after treatment. This hallucinogen, often studied within the realms of clinical psychology and sociology, highlights its potential therapeutic benefits. Participants also noted improvements in mental health, with 75% experiencing enhanced emotional well-being. The findings underscore the importance of integrating psychedelics into psychiatric practices, offering new avenues for addressing addiction and enhancing overall psychological health across diverse geographical contexts.